§ Funding Round
Apellis Pharmaceuticals raised $33M Series C venture round, led by aju ib investment.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
epidarex capitalLEAD | Organization | — |
Gerald ChanLEAD | Angel | Gerald Chan |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$140.1M
Top Valuation
-
Apellis Pharmaceuticals raised $33M in a Series C round.
The round was announced on 12/02/14.
The round was led by aju ib investment, epidarex capital, Gerald Chan.
